These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22894739)

  • 41. BRCA1 1675delA and 1135insA account for one third of Norwegian familial breast-ovarian cancer and are associated with later disease onset than less frequent mutations.
    Borg A; Dørum A; Heimdal K; Maehle L; Hovig E; Møller P
    Dis Markers; 1999 Oct; 15(1-3):79-84. PubMed ID: 10595257
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk factors for breast cancer in women under 40 years.
    Tavani A; Gallus S; La Vecchia C; Negri E; Montella M; Dal Maso L; Franceschi S
    Eur J Cancer; 1999 Sep; 35(9):1361-7. PubMed ID: 10658528
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Familial predisposition to breast cancer in a British population: implications for prevention.
    Pharoah PD; Lipscombe JM; Redman KL; Day NE; Easton DF; Ponder BA
    Eur J Cancer; 2000 Apr; 36(6):773-9. PubMed ID: 10762751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effective treatment strategy in elderly breast cancer patients].
    Boér K
    Orv Hetil; 2005 Jan; 146(1):15-21. PubMed ID: 15715368
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.
    Shu XO; Cai Q; Gao YT; Wen W; Jin F; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1462-7. PubMed ID: 14693738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Breast cancer among young U.S. women in relation to oral contraceptive use.
    White E; Malone KE; Weiss NS; Daling JR
    J Natl Cancer Inst; 1994 Apr; 86(7):505-14. PubMed ID: 8133534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Associations of obesity and physical activity with serum and intratumoral sex steroid hormone levels among postmenopausal women with breast cancer: analysis of paired serum and tumor tissue samples.
    Kakugawa Y; Tada H; Kawai M; Suzuki T; Nishino Y; Kanemura S; Ishida T; Ohuchi N; Minami Y
    Breast Cancer Res Treat; 2017 Feb; 162(1):115-125. PubMed ID: 28044214
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular Action and Clinical Relevance of Aromatase Inhibitors.
    Murphy MJ
    Oncologist; 1998; 3(2):129-130. PubMed ID: 10388095
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
    Metcalfe K; Lynch HT; Foulkes WD; Tung N; Kim-Sing C; Olopade OI; Eisen A; Rosen B; Snyder C; Gershman S; Sun P; Narod SA
    JAMA Oncol; 2015 Jun; 1(3):306-13. PubMed ID: 26181175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk and risk assessment for breast cancer: molecular and clinical aspects.
    Beckmann MW; Bani MR; Fasching PA; Strick R; Lux MP
    Maturitas; 2007 May; 57(1):56-60. PubMed ID: 17386982
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Primary breast cancer in the elderly.
    Lickley HL
    Can J Surg; 1997 Oct; 40(5):341-51. PubMed ID: 9336523
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer.
    Couch FJ; DeShano ML; Blackwood MA; Calzone K; Stopfer J; Campeau L; Ganguly A; Rebbeck T; Weber BL
    N Engl J Med; 1997 May; 336(20):1409-15. PubMed ID: 9145677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A novel BRCA-1 mutation in Arab kindred from east Jerusalem with breast and ovarian cancer.
    Kadouri L; Bercovich D; Elimelech A; Lerer I; Sagi M; Glusman G; Shochat C; Korem S; Hamburger T; Nissan A; Abu-Halaf N; Badrriyah M; Abeliovich D; Peretz T
    BMC Cancer; 2007 Jan; 7():14. PubMed ID: 17233897
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Epidemiology and endocrinology of benign breast disease.
    Wang DY; Fentiman IS
    Breast Cancer Res Treat; 1985; 6(1):5-36. PubMed ID: 3902125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study.
    Colditz GA; Willett WC; Hunter DJ; Stampfer MJ; Manson JE; Hennekens CH; Rosner BA
    JAMA; 1993 Jul; 270(3):338-43. PubMed ID: 8123079
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast Cancer beyond the Age of Mutation.
    LaBarge MA; Mora-Blanco EL; Samson S; Miyano M
    Gerontology; 2016; 62(4):434-42. PubMed ID: 26539838
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The footprint of the ageing stroma in older patients with breast cancer.
    Brouwers B; Fumagalli D; Brohee S; Hatse S; Govaere O; Floris G; Van den Eynde K; Bareche Y; Schöffski P; Smeets A; Neven P; Lambrechts D; Sotiriou C; Wildiers H
    Breast Cancer Res; 2017 Jul; 19(1):78. PubMed ID: 28673354
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations.
    Metcalfe K; Lubinski J; Lynch HT; Ghadirian P; Foulkes WD; Kim-Sing C; Neuhausen S; Tung N; Rosen B; Gronwald J; Ainsworth P; Sweet K; Eisen A; Sun P; Narod SA;
    J Natl Cancer Inst; 2010 Dec; 102(24):1874-8. PubMed ID: 21098759
    [TBL] [Abstract][Full Text] [Related]  

  • 59. To screen or not to screen: the issue of breast cancer screening in older women.
    Caplan LS
    Public Health Rev; 2001; 29(2-4):231-40. PubMed ID: 12418709
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.
    Cullinane CA; Lubinski J; Neuhausen SL; Ghadirian P; Lynch HT; Isaacs C; Weber B; Moller P; Offit K; Kim-Sing C; Friedman E; Randall S; Pasini B; Ainsworth P; Gershoni-Baruch R; Foulkes WD; Klijn J; Tung N; Rennert G; Olopade O; Couch F; Wagner T; Olsson H; Sun P; Weitzel JN; Narod SA
    Int J Cancer; 2005 Dec; 117(6):988-91. PubMed ID: 15986445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.